CYNiO GmbH

Based in Germany, CYNiO GmbH specializes in producing innovative chemical solutions, focusing on carbon dioxide-based isocyanates for specialty chemicals and R&D sectors. CYNiO GmbH focuses on the production of carbon dioxide-based isocyanates, serving the specialty chemicals and research sectors. Founded in 2024 in Germany, the company has successfully raised EUR 2 million in Seed funding led by BMP. The latest investment round occurred on June 27, 2025, bringing the total amount raised to EUR 2 million with a current valuation of EUR 9.

152 mn. CYNiO specializes in the production of carbon dioxide-based isocyanates, which serve as essential building blocks for the specialty chemicals and research and development (R&D) sectors. The company’s core product offerings include a diverse range of specialized isocyanates that are tailored to meet specific customer requests, addressing the unique needs of various industries. By utilizing a novel synthesis process that avoids the use of highly toxic phosgene, CYNiO can produce isocyanates more sustainably and cost-effectively.

The end-users of these products include researchers, industrial product developers, and companies in the chemical industry looking for innovative materials. CYNiO's geographical market primarily spans Germany and the broader European region, facilitating easier access to these specialized chemicals compared to traditional suppliers. CYNiO's revenue model is centered around B2B transactions, focusing on delivering customized isocyanates directly to clients in the specialty chemicals market. The company engages in direct sales, where clients submit specific requests detailing the desired isocyanate types, quantities, and purity levels.

Following this, CYNiO provides non-binding offers tailored to meet these specifications, fostering a strong customer partnership. The company's business transactions may involve both one-time orders and ongoing collaborations for research projects, allowing for flexibility in meeting client needs. While specific pricing structures for individual products are not disclosed, the competitive advantages offered by CYNiO are evident in their ability to produce specialized isocyanates at advantageous costs, thereby enhancing value for their customers. In June 2025, CYNiO GmbH raised EUR 2 million in Seed funding, led by BMP and with participation from CFH Management.

The company will utilize this funding to scale its sustainable technology for producing isocyanate, construct its first production facility in the Bitterfeld-Wolfen Chemical Park, and expand its product portfolio. These initiatives aim to enhance production capabilities and extend market reach.